Takai N

No ORCID on file · 11 papers in corpus · active 1995-2011

Study types

  • article 7
  • review 2
  • other 1

Condition tags

  • endometriosis 10
  • adenomyosis 2
review 2011
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/j.1447-0756.2011.01663.x

Endometriosis, a common, benign, estrogen-dependent disease affecting 3-10% of women of reproductive age, is characterized by the ectopic growth of endometrial tissue that is found primarily in the peritoneum, ovaries and rectovaginal septu…

review 2011
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719110392059

Endometriosis, a disease affecting 3% to 10% of women of reproductive age, is characterized by the ectopic growth of endometrial tissue under the influence of estrogen. It is also becoming recognized as a condition in which ectopic endometr…

article 2011
Human Reproduction ·doi:10.1093/humrep/der203

BACKGROUND: Accumulating evidence suggests that various epigenetic aberrations play definite roles in the pathogenesis of endometriosis. We investigated the histone acetylation status in endometriosis and the application of the histone deac…

article 2008
Clinical and experimental obstetrics & gynecology

It is very rare that endometriotic lesions in the rectovaginal septum cause ileus. We report a case of bowel obstruction due to endometriotic lesions in the rectovaginal septum in a 22-year-old woman whose barium enema presented with apple-…

2008
Clinical medicine. Pathology ·doi:10.4137/cpath.s487

Tamoxifen is widely used for endocrine treatment and breast cancer prevention. It acts as both an estrogen antagonist in breast tissue and an estrogen agonist in the female lower genital tract. Tamoxifen causes severe gynecologic side effec…

article 2006
American journal of physiology. Endocrinology and metabolism ·doi:10.1152/ajpendo.00135.2006

Most of the current medical treatments for endometriosis aim to downregulate estrogen activity. However, a high recurrence rate after medical treatment has been the most significant problem. BAY 11-7085, a soluble inhibitor of NK-kappaB act…

article 2006
Human Reproduction ·doi:10.1093/humrep/del270

BACKGROUND: Most of the current medical treatments for endometriosis aim to down-regulate the estrogen activity. However, a high recurrence rate after medical treatments has been the most significant problem. Beta-hydroxyisovalerylshikonin …

article 2005
Molecular human reproduction ·doi:10.1093/molehr/gah249

Most of the current medical treatments for endometriosis aim to down-regulate the estrogen activity. However, a high recurrence rate after medical treatments has been the most significant problem. Bufalin is a major digoxin-like immunoreact…

article 2004
Molecular human reproduction ·doi:10.1093/molehr/gah133

In order to evaluate the involvement of cell proliferation and apoptosis in the pathogenesis of endometriosis, we investigated the effects of interferon-gamma (IFN-gamma) on cell growth inhibition and apoptosis of cultured ovarian endometri…

article 1999
Gynecologic and obstetric investigation ·doi:10.1159/000010139

In spite of many references to carcinoma arising from endometriosis at extrauterine sites, there are few documented cases of carcinoma developing in association with adenomyosis. We present 2 rare cases of adenocarcinoma arising from adenom…

other 1995
Human Reproduction ·doi:10.1093/oxfordjournals.humrep.a136065

Using immunohistochemical techniques, we studied the expression of c-erb B-2 in normal human endometrial tissue (n = 8), endometriosis interna (adenomyosis) (n = 8) and endometriosis externa (endometriotic cyst of the ovary) (n = 6). The gl…